Target intelligence / Profile preview

WD repeat-containing protein 91 (WDR91)

Target
WDR91
Molecular classification
WD repeat protein, Other
01

Overview

WD repeat-containing protein 91 (WDR91) is a WD40-repeat scaffold protein that functions as an essential effector of the small GTPase Rab7, playing a critical role in endosomal maturation by regulating the conversion between early and late endosomes[1][2][3][5]. It is specifically recruited to endosomal membranes through the interaction with active Rab7 and acts as a negative regulator of phosphatidylinositol 3-kinase (PI3K) activity, controlling levels of phosphatidylinositol 3-phosphate (PtdIns3P) to ensure proper endosomal maturation and trafficking[1][3][5]. WDR91 is a key part of the WDR81-WDR91 complex, which mediates efficient endolysosomal compartment fusion, thereby supporting the lysosomal degradation of surface receptors and endocytosed cargo[1]. Loss or dysfunction of WDR91 impairs endosomal transport and lysosomal degradation functions and is implicated in affecting neuronal development and associated with neurodegenerative phenotypes in genetic studies[1][5]. According to current data, WDR91 is not a direct therapeutic target, receptor, or enzyme, and there are no drugs or biomarkers currently known to interact with or act on WDR91[1][5].

Other names
SORF-1SORF1HSPC049
02

Biological functions

Endosomal maturationEndosome transportProtein catabolic processVesicular traffickingEndolysosomal compartment fusionRegulation of phosphoinositide metabolismProtein-protein interaction platformOther
03

Disease associations

Neurodevelopmental disorderFrontotemporal dementia and/or amyotrophic lateral sclerosisOther

Beyond the preview

Go deeper on WD repeat-containing protein 91 (WDR91).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WD repeat-containing protein 91 (WDR91).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call